Skip to search formSkip to main contentSkip to account menu

SCH 48461

Known as: SCH-48461 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2004
Review
2004
Beta-lactam cholesterol absorption inhibitors.
beta-Lactams have recently been identified as potent, highly efficacious cholesterol absorption inhibitors (CAIs). The discovery… 
2004
2004
Effect of a New b-Sitosterol Analogue on Plasma Lipid Concentrations in Rats 1 )
disease (CHD) or atherosclerosis is elevated levels of serum cholesterol. Recent clinical trials and studies have confirmed that… 
Review
2003
Review
2003
Ezetimibe for Management of Hypercholesterolemia
OBJECTIVE: To review the primary literature describing the pharmacology of ezetimibe and clinical trials investigating its use in… 
2002
2002
Synthesis of iodinated biochemical tools related to the 2-azetidinone class of cholesterol absorption inhibitors.
1997
1997
Spectroscopic identification of an amorphous-to-crystalline drug transition in a solid dispersion SCH 48461 capsule formulation.
1996
1996
Effect of SCH 48461 on oral cholesterol absorption
Clinical Pharmacology & Therapeutics (1996) 59, 194–194; doi: 10.1038/sj.clpt.1996.274 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)